The in vitro effects of moxalactam and gentamicin on chemotactic, phagocytic, and microbicidal activities of human polymorphonuclear leukocytes have been studied. Incubation of cells with moxalactam (25 to 400 ,ug/ml) resulted in a 10 to 15% inhibition of leukocyte chemotaxis (P s 0.10). Incubation of cells with gentamicin (5 to 40 p.g/ml) inhibited chemotaxis more than 50% (P < 0.50).
The in vitro effects of moxalactam and gentamicin on chemotactic, phagocytic, and microbicidal activities of human polymorphonuclear leukocytes have been studied. Incubation of cells with moxalactam (25 to 400 ,ug/ml) resulted in a 10 to 15% inhibition of leukocyte chemotaxis (P s 0.10). Incubation of cells with gentamicin (5 to 40 p.g/ml) inhibited chemotaxis more than 50% (P < 0.50).
Neither moxalactam nor gentamicin had any effect on phagocytic or microbicidal capacities of leukocytes.
Several antimicrobial agents purportedly interfere with the functions of human polymorphonuclear (PMN) cells (1, 3) . Erythromycin, tetracycline, rifampin, aminoglycosides, and chloramphenicol inhibit the chemotactic activity of granulocytes in vitro (4, 8, 12, 14) . Most betalactam drugs do not affect leukocyte functions but cefoxitin at therapeutic levels has recently been shown to interfere with the chemotaxis of PMN cells in vitro (13) .
Moxalactam, a relatively new beta-lactam active in vitro against a broad spectrum of facultative and anaerobic bacteria, can frequently replace aminoglycosides such as gentamicin. It is important therefore to know how these agents affect leukocyte functions.
The purpose of our work has been to compare effects of moxalactam and gentamicin on migration, phagocytosis, and microbicidal capacity of human PMN leukocytes. (15) . Agarose solution was prepared on tissue culture medium 199 (Flow Laboratories) and complemented with 10% inactivated fetal calf serum and 1% glutamine at a final concentration of 0.75%. We then transferred 5 ml of the agarose solution to a tissue culture dish (60 by 15 mm; Corning 25010), and the solution was allowed to harden. Three series of three wells, 3 mm in diameter and spaced 2 mm apart, were cut in each plate. We added 10 ,u1 of each cell suspension to the central wells of each plate. Interior wells were filled with 10 p.1 of Gey's solution for random migration. The three exterior wells of each plate were filled with 10 ,ul of zymosan-activated serum, which served as the chemotactic factor. Plates were incubated under a humidified atmosphere with 5% CO2-Cell migration was then read under the microscope (x 100) with a microscale, using the difference between stimulated and random migration as effective migration. Phagocytosis and microbicidal capacity. The percentage of phagocytosis was 85 ± 8 and 84 ± 10% after cell exposure to moxalactam and gentamicin, respectively, and 78 ± 4% in the control group. The phagocytic index shows that each control preparation has a mean of 1.1 ± 0.2 candidas, each moxalactam preparation has a mean of 1.4 ± 0.2 candidas, and each gentamicin preparation has a mean of 1.5 ± 0.2 candidas; there is no statistically significant difference between any group (P s 0.5, Student's t test).
The numbers of candida lysed after ingestion were 41 ± 4 and 44 ± 4 in the moxalactam-and gentamicin-incubated cells and 48 ± 4 in the control cells. None of these three parameters was affected by the two antibiotics tested.
DISCUSSION
Various investigators have shown that the functional activity of human PMN leukocytes can be altered by certain antibiotics (2, 4, 10, 12) . Tetracyclines, erythromycin, and rifampin (4, 11, 12, 14) reportedly interfere with chemotaxis of human PMN cells; results with chloramphenicol and aminoglycosides are contradictory (4, 6, 8, 12) . Phagocytosis is inhibited by tetracycline or chloramphenicol (5, 7, 10), but is not modified by aminoglycosides or cephalosporins (13, 16, 17) .
In our experiments with different concentrations of gentamicin, cell migration was inhibited significantly. These results are similar to those of Khan et al. (8) , but differ from those of Forsgren and Schmeling, who found no inhibition of chemotaxis by gentamicin (4) . Of the various beta-lactam drugs examined thus far, cefamandole was without effect on chemotaxis, opsonization, or phagocytosis of human PMN cells (13) , whereas cefoxitin has an inhibitory effect on the chemotaxis of PMN cells (13) . In our study, chemotaxis of cells was unaffected by preincubation with different concentrations of moxalactam.
Inhibition of chemotaxis by tetracyclines and 1gentamicin is mediated by the inactivation of human complement fraction 3 (1, 11) . To also exclude this mechanism, moxalactam (25 to 50 jig/ml) was preincubated with serum, and the chemotactic capacity of that serum was not diminished. When we tested phagocytosis and killing capacity, neither gentamicin nor moxalactam interfered with those functions. The broad spectrum of in vitro activity of moxalactam, its low toxicity, and preliminary clinical results have made this drug a potentially useful agent for the treatment of severe infections in the compromised host. Even though the clinical significance of these laboratory findings is generally unknown, it seems desirable, especially when dealing with compromised hosts, to use antibiotics that do not interfere with natural host defense mechanisms (1, 3 
